Bioactive Compounds
-
B7399 YM 202074Summary: metabotropic glutamate receptor type 1 (mGlu1) antagonist -
BA2756 ONC212Summary: ONC212, a fluorinated ONC201 analog, is a promising anticancer agent and selective agonist. -
A9982 Vipivotide tetraxetanSummary: A potent prostate-specific membrane antigen (PSMA) inhibitor -
N2849 Rehmannioside ASummary: A steroid glycoside -
BA3927 TretazicarSummary: Tretazicar (CB1954) is an antitumor precursor with high potency and selectivity against the Walker256 rat tumor cell line. -
BA4066 5-O-DMT-N6-Me-2-dASummary: A nucleoside with protective and modifying effects. -
B3179 PTC-209Target: BMI-1Summary: Bmi-1 inhibitor,cell-permeable and small-molecule -
B3291 Walrycin BSummary: WalR inhibitor -
B7949 LiraglutideTarget: GLP-1 receptor -
B8215 JNJ-47965567

